The method is also useful for treating prostate tumors or benign prostatic hyperplasia/hypertrophy (BPH).

The compounds of the present invention are useful for treating benign prostatic hyperplasia (BPH).

One of the most common causes of an obstruction is an enlarged prostate (a condition called benign prostatic hyperplasia) which can often be treated effectively with medication.

The histological basis of BPH is benign hyperplasia, whose origin is not entirely clear.

This pharmaceutical composition assists in the treatment of benign prostate hyperthropy and breast cancer etc.

In men with benign prostatic hypertrophy, drugs (usually ?-adrenergic blockers or 5?-reductase inhibitors) or surgery may help decrease bladder outlet resistance.

And all guys over 50 should recognise their leading most typical prostate problem, which is an enlarged prostate, or benign prostatic hypertrophy.

Compositions and methods are described for the treatment of prostatitis, benign prostatic hypertrophy, and prostate cancer.

And all men over 50 should be aware of their number one most common prostate problem, which is an enlarged prostate, or benign prostatic hypertrophy.

Patients with urinary conditions including benign prostatic hypertrophy, stricture of the urethra.

This invention relates to novel inhibitors of androgen synthesis that are useful in the treatment of prostate cancer and benign prostatic hypertrophy.

Patients with urinary conditions including benign prostatic hypertrophy, stricture of the urethra.

Other uses for Cialis also include treatment of the symptoms of enlarged prostate, or benign prostatic hypertrophy.

A method for treatment or prophylaxis of benign prostatic hyperplasia by administration of lonidamine or a lonidamine analog is provided.

Finasteride is used to prevent the urinary problems faced by men due to benign prostatic hypertrophy (BPH).